Fishers, IN, United States of America

Mark A Jarosinski

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 2.9

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Boulder, CO (US) (2001)
  • Fishers, IN (US) (2009 - 2012)

Company Filing History:


Years Active: 2001-2012

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: Mark A Jarosinski: Innovator in Therapeutic Peptides

Introduction

Mark A Jarosinski is a notable inventor based in Fishers, IN (US). He has made significant contributions to the field of therapeutic peptides, particularly in the development of bradykinin B1 receptor antagonists. With a total of 4 patents, his work has the potential to impact treatments for various inflammatory conditions.

Latest Patents

Jarosinski's latest patents focus on the composition of matter involving bradykinin B1 receptor antagonist peptides. One of his inventions involves peptides conjugated to a univalent vehicle, including univalent PEG. These compositions can serve as therapeutics or prophylactics against diseases linked to the bradykinin B1 receptor, such as inflammation or pain. Another patent details similar compositions but with peptides conjugated to a multivalent vehicle, including multivalent PEG, further expanding the potential applications of his work.

Career Highlights

Mark A Jarosinski is currently employed at Amgen Inc., a leading biotechnology company. His role involves research and development in the field of therapeutic peptides, where he applies his expertise to create innovative solutions for medical challenges.

Collaborations

Throughout his career, Jarosinski has collaborated with notable colleagues, including Gordon Ng and Benny C Askew. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Mark A Jarosinski is a distinguished inventor whose work in therapeutic peptides has the potential to transform treatment options for inflammatory conditions. His contributions to the field are marked by his innovative patents and collaborations with esteemed colleagues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…